最新ニュース KE Holdings (NYSE:BEKE) 株価情報

KE Holdings

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2023, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

KE Holdings Inc

Bekem Metals Inc

On Friday, the FDA accepted for review the resubmission of the supplemental biologics license application (sBLA) for Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) and Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent (dupilumab) for patients ages 12 years and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 <a href="https://www.benzinga.com/pressreleases/24/11/g42000231/press-release-dupixent-sbla-accepted-for-fda-review-for-the-treatment-of-chronic-spontaneous-urtic" target="_blank" rel="noreferrer noopener">antihistamine treatment</a>.
The target action date for the FDA decision is April 18, 2025.
Data from the multi-study LIBERTY-CUPID phase 3 clinical program (<a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2021/2021-07-29-05-00-00-2270858" rel="noreferrer noopener">Study A</a>,&nbsp;<a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2022/2022-02-18-06-00-00-2387700" rel="noreferrer noopener">Study B</a>, and&nbsp;<a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2024/2024-09-11-05-05-00-2944239" rel="noreferrer noopener">Study C</a>) for Dupixent in CSU support the resubmitted supplemental marketing.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41945225/regeneron-sanofis-dupixent-approval-signals-major-treatment-breakthrough-for-smokers-lung-disease" rel="noreferrer noopener">Regeneron/Sanofi&#8217;s Dupixent Approval Signals Major Treatment Breakthrough For Smokers&#8217; Lung Disease</a>
Earlier this year, Japan was the first country in the world to&nbsp;approve&nbsp;and launch Dupixent for adult and adolescent CSU patients based on the results <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40814475/sanofi-regeneron-drug-dupixent-shows-successful-treatment-of-patients-with-inflammatory-skin-dise" rel="noreferrer noopener">from Study A</a>.
The supplemental marketing adds results from Study C, conducted in patients with uncontrolled CSU who were on standard-of-care antihistamines. Study C, the second LIBERTY-CUPID pivotal study in biologic-naïve patients, met its primary and key secondary endpoints, confirming the results of the previous Study A.
Results showed that Dupixent significantly reduced itch and urticaria activity (itch and hives).
In March 2023, the FDA <a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-07-06-00-00-2621670" rel="noreferrer noopener">accepted</a> the supplemental marketing application for Dupixent&nbsp;(dupilumab) to treat adults and adolescents with chronic spontaneous urticaria, with the target action date for the FDA decision of October 22, 2023.
In October 2023, the FDA <a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2023/2023-10-20-21-00-00-2764252" rel="noreferrer noopener">issued</a> a Complete Response Letter for the supplemental Biologics License Application and stated that additional efficacy data are required to support approval.
It did not identify any issues with safety or manufacturing.
CSU is a chronic inflammatory skin disease driven partly by type-2 inflammation, which causes sudden hives and recurring itch.
CSU is typically treated with H1 antihistamines, medicines that target H1 receptors on cells to control urticaria symptoms.
More than 300,000 people in the US suffer from CSU that is inadequately controlled by antihistamines.
Price Action: REGN stock closed at $782.51 on Thursday, and SNY stock is up 1.09% at $48.34 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/41987383/unitedhealths-optum-defends-multi-billion-dollar-amedisys-deal-ensures-competitive-landscape" target="_blank" rel="noreferrer noopener">UnitedHealth&#8217;s Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

News

Health Care

General

REGN

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

WIIM

OneStream shares are trading lower after the company announced a 15 million class A common stock secondary offering.

InMed Pharmaceuticals shares are trading lower after the company reported a year-over-year decrease in Q4 EPS results.

Earnings

Know Labs FY24 EPS  $(0.20) vs $(0.41) YoY

Company's Rapid Alcohol-Reducing Beverage, Sure Shot, to be Sold in 192 Stores Across Nevada, Arizona, and California
JUPITER, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOT#NASDAQ">SHOT</a>) ("Safety Shot" or "the Company") today announced a new agreement with a leading national grocery chain to sell its convenient, newly branded 4 oz. Sure Shot beverages in select stores across the Southwest. This chain boasts over 2,200 stores nationwide, making them a significant player in the grocery industry.
This strategic launch in 192 stores across Nevada, Arizona, and California represents a significant milestone in Safety Shot's growth strategy. It provides access to a substantial and rapidly growing alcohol beverage market and marks a key step towards the Company's goal of nationwide distribution.

SHOT

Safety Shot Announced A New Agreement With A Leading National Grocery Chain To Sell Its Convenient, Newly Branded 4 Oz. Sure Shot Beverages In Select Stores Across The Southwest

Evercore ISI Group analyst Duane Pfenningwerth downgrades Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) from Outperform to In-Line and maintains the price target from $10.5 to $10.5.

Downgrades

Price Target

Analyst Ratings

Evercore ISI Group Downgrades Diamondrock Hospitality to In-Line, Maintains Price Target to $10.5

RVYL

Ryvyl shares are trading lower. HC Wainwright & Co. reiterated a Neutral rating on the stock.

<a href="https://www.globenewswire.com/Tracker?data=oitox4x61cysgmwWmH-4y0XEjZKDx7vc9SYpYpngH33pFS6I3IlY-q-LsjR9lIzyVSYOkq29dQRMXutaPBuvrmxtA0l3Px7d-VkLvq27Yf5vY5uqf3Do5mhfCjwAUgGo">SeaStar Medical Holding Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, has begun shipping QUELIMMUNE&#x2122; to a third hospital customer. QUELIMMUNE is the Company's Selective Cytopheretic Device (SCD) for treating critically ill children in the intensive care unit (ICU) with acute kidney injury (AKI) and sepsis.

SeaStar Medical Reaches Milestone Of 100th QUELIMMUNE Commercial Device As Shipments Begin To Its Third Hospital Customer

Lument Finance Trust shares are trading higher following a Q3 earnings beat.

SPPL

SIMPPLE shares are trading higher after the company announced a $400,000 contract to supply autonomous cleaning robots at Singapore's International Airport Terminal.

SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) reported quarterly losses of $(0.25) per share. This is a 74.75 percent increase over losses of $(0.99) per share from the same period last year. The company reported $881.69 thousand in sales this quarter. This is a 34.66 percent decrease over sales of $1.35 million the same period last year.

SBET

SharpLink Gaming Q3 EPS $(0.25) Up From $(0.99) YoY, Sales $881.69K Down From $1.35M YoY

LIFW

MSP Recovery shares are trading lower. The company reported Q3 financial results.

BTOC

Armlogi Q1 Total Revenue $42.5M, Up 3% YoY; EPS $(0.11) vs $0.07 YoY

SharpLink Gaming Q3 Revenue $881.690K Down From $1.349M YoY

SIMPPLE Ltd. (NASDAQ:<a href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) ("SIMPPLE" or "the Company"), a leading technology provider and innovator in the facilities management (FM) sector, today announced that the Company has been awarded a $400,000 contract for the supply of autonomous cleaning robotics at one of Singapore's international airport terminals.
This robot tender success comes as part of the airport's renewal program and complements the existing fleet of autonomous cleaning robots across its airport terminals, where the Company has been one of two incumbent robotic suppliers for the past five years.
The results of the ongoing tender exercise for the remaining airport terminals will be announced in the near future, with an expected aggregate contract value of $1.8 million.

Contracts

Global

SIMPPLE Wins $400,000 Contract To Supply Autonomous Cleaning Robots At Singapore's International Airport Terminal; The Results Of The Ongoing Tender Exercise For The Remaining Airport Terminals Will Be Announced In The Near Future, With An Expected Aggregate Contract Value Of $1.8M

PHIO

Phio Pharma shares are trading higher. The company reported Q3 financial results.

EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>), the world's leading Urban Air Mobility ("UAM") technology platform company, today announced that it has signed a cooperation framework agreement ("Agreement") with Zhejiang Sunriver Culture and Tourism Co., Ltd. ("Sunriver", 600576.SH), a China A-share listed company, to explore an industrial model that integrates low-altitude economy with cultural tourism in China. Under the Agreement, Sunriver plans to purchase 50 units of EH216-S or similar pilotless passenger-carrying aircraft from EHang for its cultural tourism projects based on market development needs. Sunriver has placed a purchase order for 5 units of EH216-S as the first batch for aerial tourism use cases. The remaining aircraft will be gradually deployed in the tourism attractions under the Sunriver.

EHang Partners with Sunriver To Expand Chinese Cultural Tourism Market With Purchase Plan For 50 Units Of EH216-S Or Similar Pilotless Passenger-Carrying Aircraft From EHang For Its Cultural Tourism Projects Based On Market Development Needs

Suburban Propane Partners, L.P. (NYSE:<a href="https://www.benzinga.com/stock/SPH#NYSE">SPH</a>), a nationwide distributor of propane, renewable propane, renewable natural gas, fuel oil and related products and services, as well as a marketer of natural gas and electricity and investor in low carbon fuel alternatives, announced today an executive promotion in line with its planned management succession. As previously announced, Steven C. Boyd, the Partnership's Chief Operating Officer, will retire effective January 1, 2025.
The Partnership announced that Alejandro ("Alex") Centeno has been promoted to Senior Vice President – Operations as successor to Mr. Boyd. In his role, Mr.&nbsp;Centeno will report to Michael A. Stivala, President and Chief Executive Officer. Mr.&nbsp;Centeno has been with the Partnership for over 15 years, where he has held several managerial positions within the operations, most recently, rising to the level of Vice President – Operations since August 2023. In his new position, Mr.&nbsp;Centeno will be responsible for leading all aspects of the day-to-day operations of the propane business, as well as advancing the Partnership's customer base growth and retention initiatives, driving continued improvements in operational efficiencies and overseeing operational support functions; including safety, marketing and fleet management.&nbsp;

Management

Suburban Propane Partners, L.P.'s Steven C. Boyd, The Partnership's Chief Operating Officer, Will Retire Effective January 1, 2025; Alejandro ("Alex") Centeno Has Been Promoted To Senior Vice President – Operations As Successor To Mr. Boyd

Benchmark analyst Daniel Kurnos maintains Cineverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) with a Speculative Buy and raises the price target from $9 to $10.

CNVS

Benchmark Maintains Speculative Buy on Cineverse, Raises Price Target to $10

AKAM

Akamai Is The Winning Bidder To Acquire Select Assets From Edgio, Including Customer Contracts From Edgio's Businesses In Security And Content Delivery, And Non-Exclusive License Rights To Edgio's Entire Patent Portfolio

Baird Q3 2024 International And Global Growth Fund Commentary

UP Fintech stock slides, LexinFintech jumps after China's latest economic measures

BofA upgraded KE Holdings (BEKE) to Buy from Neutral with a price target of $28, up from $24. Published first on TheFly – the ultimate source for r...

KE Holdings upgraded to Buy from Neutral at BofA

BofA analyst Miranda Zhuang upgraded KE Holdings (BEKE) to Buy from Neutral with a price target of $28, up from $24. KE is the "clear market leader...

BofA upgrades KE Holdings to Buy on China policy pivot

KE Holdings raised to Buy as BofA calls it a beneficiary of China stimulus

In a report released today, Jiong Shao from Barclays maintained a Buy rating on KE Holdings Inc. Sponsored ADR Class A (BEKE – Research Report), wi...

KE Holdings Inc. Sponsored ADR Class A (BEKE) Gets a Buy from Barclays

Chinese stocks and ETFs slide amid Trump victory as higher tariffs are anticipated

Bullish option flow detected in KE Holdings (BEKE) with 30,013 calls trading, 1.6x expected, and implied vol increasing over 1 point to 68.83%. 11/...

KE Holdings call volume above normal and directionally bullish

Walt Disney, Cisco, And Shopify Headline Latest Earnings Week

KE Holdings Inc. Sponsored ADR Class A (BEKE) has released an update. KE Holdings Inc. has announced changes in its share structure, including the ...

KE Holdings Inc. Announces Share Repurchase and Conversion

AAPL

ADYEY

ADYYF

ALCN

AMAT

AMZN

ANGI

APTV

ARMK

ASHR

ASML

ASMLF

BABA

BABAF

BBWI

BEIGF

BEKE

BGNE

BIDU

BKRKF

BKRKY

BRENF

CHIQ

CNYA

CPRT

CQQQ

CSCO

CWEB

CXSE

CYBR

EVGO

EXTR

FINV

FUTU

GMAB

GNMSF

GOOG

GOOGL

JDZG

KLIP

KWEB

LAZR

MCHI

NONOF

NTES

NVDA

PAYO

PPRUF

PPRUY

PROSF

PROSY

RCRRF

RCRUY

RMLFF

RYAAY

RYAOF

SCHW

SHOP

SPOT

STLA

SZKMF

SZKMY

TALO

TEAM

TIGR

TSEM

TSMWF

WELL

WXIBF

WXXWY

YANG

YINN

YUMC

ZETA

Press Releases

KE Holdings Inc. to Hold Annual General Meeting on June 14, 2024

KE Holdings Inc. Releases 2023 Environmental, Social and Governance Report

KE Holdings Inc. Files Its Annual Report on Form 20-F

KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time

KE Holdings Inc. Announces First Quarter 2024 Unaudited Financial Results

KE Holdings Inc. Announces Results of Annual General Meeting

KE Holdings Inc. to Report Second Quarter 2024 Financial Results on August 12, 2024 Eastern Time

KE Holdings Inc. Announces Second Quarter 2024 Unaudited Financial Results and Upsizing and Extension of Share Repurchase Program

KE Holdings Inc. Announces Upsizing and Extension of Share Repurchase Program

KE Holdings Inc. to Report Third Quarter 2024 Financial Results on November 21, 2024 Eastern Time

Comments

KE Holdings

ニュース

最新ニュース KE Holdings (NYSE:BEKE) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル